News
5h
TipRanks on MSNCRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and IridiumAce hedge fund manager Cathie Wood made some interesting trades on July 25, according to ARK Invest’s daily trade updates. Wood sold $16.46 ...
Veracyte (VCYT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
We recently published 10 Shares Explode as Earnings Impress. Veracyte, Inc. (NASDAQ:VCYT) is one of the best-performing ...
Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.
(Nasdaq: VCYT), a leading cancer diagnostics company, today announced that three Afirma-related abstracts will be presented at ENDO 2025, the annual meeting of the Endocrine Society, taking place July ...
View the latest Veracyte Inc. (VCYT) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Explore more
Biotechnology company Veracyte (VCYT) is set to replace Triumph Group (TGI) in the S&P SmallCap 600 index prior to the market open on Tuesday, July 29.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results